Hagen P, D'Souza A, Hari P, Davila O, et al. Busulfan, melphalan, and bortezomib compared to melphalan as a high dose regimen for autologous hematopoietic stem cell transplantation in multiple myeloma: long term follow up of a novel high dose regimen. Leuk Lymphoma 2020 Aug 31:1-9. doi: 10.1080/10428194.2020.1811275.
PMID: 32865474